178 related articles for article (PubMed ID: 21310833)
1. Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.
Malaguarnera M; Vacante M; Giordano M; Pennisi G; Bella R; Rampello L; Malaguarnera M; Li Volti G; Galvano F
Am J Clin Nutr; 2011 Apr; 93(4):799-808. PubMed ID: 21310833
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.
Malaguarnera M; Vacante M; Motta M; Giordano M; Malaguarnera G; Bella R; Nunnari G; Rampello L; Pennisi G
Metab Brain Dis; 2011 Dec; 26(4):281-9. PubMed ID: 21870121
[TBL] [Abstract][Full Text] [Related]
3. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
Malaguarnera M; Gargante MP; Cristaldi E; Vacante M; Risino C; Cammalleri L; Pennisi G; Rampello L
Dig Dis Sci; 2008 Nov; 53(11):3018-25. PubMed ID: 18357530
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
Malaguarnera M; Bella R; Vacante M; Giordano M; Malaguarnera G; Gargante MP; Motta M; Mistretta A; Rampello L; Pennisi G
Scand J Gastroenterol; 2011 Jun; 46(6):750-9. PubMed ID: 21443422
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
6. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
[TBL] [Abstract][Full Text] [Related]
7. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine in hepatic encephalopathy.
Malaguarnera M
Metab Brain Dis; 2013 Jun; 28(2):193-9. PubMed ID: 23389620
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
Rossini M; Di Munno O; Valentini G; Bianchi G; Biasi G; Cacace E; Malesci D; La Montagna G; Viapiana O; Adami S
Clin Exp Rheumatol; 2007; 25(2):182-8. PubMed ID: 17543140
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-carnitine in patients with hepatic encephalopathy.
Malaguarnera M; Pistone G; Elvira R; Leotta C; Scarpello L; Liborio R
World J Gastroenterol; 2005 Dec; 11(45):7197-202. PubMed ID: 16437672
[TBL] [Abstract][Full Text] [Related]
11. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial.
Malaguarnera M; Cammalleri L; Gargante MP; Vacante M; Colonna V; Motta M
Am J Clin Nutr; 2007 Dec; 86(6):1738-44. PubMed ID: 18065594
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.
Hershman DL; Unger JM; Crew KD; Minasian LM; Awad D; Moinpour CM; Hansen L; Lew DL; Greenlee H; Fehrenbacher L; Wade JL; Wong SF; Hortobagyi GN; Meyskens FL; Albain KS
J Clin Oncol; 2013 Jul; 31(20):2627-33. PubMed ID: 23733756
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
Cai XJ; Wang L; Hu CM
J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
[TBL] [Abstract][Full Text] [Related]
14. Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine.
Jiang Q; Jiang G; Shi KQ; Cai H; Wang YX; Zheng MH
Ann Hepatol; 2013; 12(5):803-9. PubMed ID: 24018499
[TBL] [Abstract][Full Text] [Related]
15. Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study.
Memeo A; Loiero M
Clin Drug Investig; 2008; 28(8):495-500. PubMed ID: 18598095
[TBL] [Abstract][Full Text] [Related]
16. Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome.
Vermeulen RC; Scholte HR
Psychosom Med; 2004; 66(2):276-82. PubMed ID: 15039515
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial.
Malaguarnera M; Pistone G; Astuto M; Vecchio I; Raffaele R; Lo Giudice E; Rampello L
Dig Dis Sci; 2006 Dec; 51(12):2242-7. PubMed ID: 17080254
[TBL] [Abstract][Full Text] [Related]
18. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.
Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M
Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628
[TBL] [Abstract][Full Text] [Related]
19. Carnitine for fatigue in multiple sclerosis.
Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
Cochrane Database Syst Rev; 2012 May; 2012(5):CD007280. PubMed ID: 22592719
[TBL] [Abstract][Full Text] [Related]
20. The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin.
Malaguarnera M; Vacante M; Bertino G; Neri S; Malaguarnera M; Gargante MP; Motta M; Lupo L; Chisari G; Bruno CM; Pennisi G; Bella R
J Interferon Cytokine Res; 2011 Sep; 31(9):653-9. PubMed ID: 21923249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
